141 related articles for article (PubMed ID: 27941932)
1. Sharpin promotes hepatocellular carcinoma progression via transactivation of Versican expression.
Tanaka Y; Tateishi K; Nakatsuka T; Kudo Y; Takahashi R; Miyabayashi K; Yamamoto K; Asaoka Y; Ijichi H; Tateishi R; Shibahara J; Fukayama M; Ishizawa T; Hasegawa K; Kokudo N; Koike K
Oncogenesis; 2016 Dec; 5(12):e277. PubMed ID: 27941932
[TBL] [Abstract][Full Text] [Related]
2. SHARPIN overexpression promotes TAK1 expression and activates JNKs and NF-κB pathway in Mycosis Fungoides.
Chen B; Zheng Y; Zhu J; Liang Y
Exp Dermatol; 2019 Nov; 28(11):1279-1288. PubMed ID: 31461795
[TBL] [Abstract][Full Text] [Related]
3. Activation of nuclear factor κB pathway and downstream targets survivin and livin by SHARPIN contributes to the progression and metastasis of prostate cancer.
Zhang Y; Huang H; Zhou H; Du T; Zeng L; Cao Y; Chen J; Lai Y; Li J; Wang G; Guo Z
Cancer; 2014 Oct; 120(20):3208-18. PubMed ID: 24925528
[TBL] [Abstract][Full Text] [Related]
4. Metallothionein 1H (MT1H) functions as a tumor suppressor in hepatocellular carcinoma through regulating Wnt/β-catenin signaling pathway.
Zheng Y; Jiang L; Hu Y; Xiao C; Xu N; Zhou J; Zhou X
BMC Cancer; 2017 Feb; 17(1):161. PubMed ID: 28241806
[TBL] [Abstract][Full Text] [Related]
5. Overexpression of SHARPIN promotes tumor progression in ovarian cancer.
Wang G; Zhuang Z; Cheng J; Yang F; Zhu D; Jiang Z; Du W; Shen S; Huang J; Hua L; Chen Y
Exp Mol Pathol; 2022 Jul; ():104806. PubMed ID: 35798064
[TBL] [Abstract][Full Text] [Related]
6. MicroRNA-504 functions as a tumor suppressor in hepatocellular carcinoma through inhibiting Frizzled-7-mediated-Wnt/β-catenin signaling.
Quan H; Li B; Yang J
Biomed Pharmacother; 2018 Nov; 107():754-762. PubMed ID: 30142536
[TBL] [Abstract][Full Text] [Related]
7. HEG1 indicates poor prognosis and promotes hepatocellular carcinoma invasion, metastasis, and EMT by activating Wnt/β-catenin signaling.
Zhao YR; Wang JL; Xu C; Li YM; Sun B; Yang LY
Clin Sci (Lond); 2019 Jul; 133(14):1645-1662. PubMed ID: 31278131
[TBL] [Abstract][Full Text] [Related]
8. NTS/NTR1 co-expression enhances epithelial-to-mesenchymal transition and promotes tumor metastasis by activating the Wnt/β-catenin signaling pathway in hepatocellular carcinoma.
Ye Y; Long X; Zhang L; Chen J; Liu P; Li H; Wei F; Yu W; Ren X; Yu J
Oncotarget; 2016 Oct; 7(43):70303-70322. PubMed ID: 27611941
[TBL] [Abstract][Full Text] [Related]
9. Transcription factor AP-4 promotes tumorigenic capability and activates the Wnt/β-catenin pathway in hepatocellular carcinoma.
Song J; Xie C; Jiang L; Wu G; Zhu J; Zhang S; Tang M; Song L; Li J
Theranostics; 2018; 8(13):3571-3583. PubMed ID: 30026867
[TBL] [Abstract][Full Text] [Related]
10. A novel SHARPIN-PRMT5-H3R2me1 axis is essential for lung cancer cell invasion.
Fu T; Lv X; Kong Q; Yuan C
Oncotarget; 2017 Aug; 8(33):54809-54820. PubMed ID: 28903384
[TBL] [Abstract][Full Text] [Related]
11. SHARPIN Promotes Melanoma Progression via Rap1 Signaling Pathway.
Zhou S; Liang Y; Zhang X; Liao L; Yang Y; Ouyang W; Xu H
J Invest Dermatol; 2020 Feb; 140(2):395-403.e6. PubMed ID: 31401046
[TBL] [Abstract][Full Text] [Related]
12. Kindlin-2 promotes hepatocellular carcinoma invasion and metastasis by increasing Wnt/β-catenin signaling.
Lin J; Lin W; Ye Y; Wang L; Chen X; Zang S; Huang A
J Exp Clin Cancer Res; 2017 Sep; 36(1):134. PubMed ID: 28969700
[TBL] [Abstract][Full Text] [Related]
13. Shank-associated RH domain-interacting protein expression is upregulated in entodermal and mesodermal cancer or downregulated in ectodermal malignancy.
Liang Y; Chen B; Liu F; Wang J; Yang Y; Zheng Y; Tan S
Oncol Lett; 2018 Dec; 16(6):7180-7188. PubMed ID: 30546455
[TBL] [Abstract][Full Text] [Related]
14. Elevation of SIPL1 (SHARPIN) Increases Breast Cancer Risk.
De Melo J; Tang D
PLoS One; 2015; 10(5):e0127546. PubMed ID: 25992689
[TBL] [Abstract][Full Text] [Related]
15. Mapping of the Wnt/β-catenin/TCF response elements in the human versican promoter.
Rahmani M; Carthy JM; McManus BM
Methods Mol Biol; 2012; 836():35-52. PubMed ID: 22252626
[TBL] [Abstract][Full Text] [Related]
16. Shank-associated RH domain interactor signaling in tumorigenesis.
Zeng C; Xiong D; Zhang K; Yao J
Oncol Lett; 2020 Sep; 20(3):2579-2586. PubMed ID: 32782575
[TBL] [Abstract][Full Text] [Related]
17. Versican gene: regulation by the β-catenin signaling pathway plays a significant role in dermal papilla cell aggregative growth.
Yang Y; Li Y; Wang Y; Wu J; Yang G; Yang T; Gao Y; Lu Y
J Dermatol Sci; 2012 Dec; 68(3):157-63. PubMed ID: 23099107
[TBL] [Abstract][Full Text] [Related]
18. Downregulation of miR-610 promotes proliferation and tumorigenicity and activates Wnt/β-catenin signaling in human hepatocellular carcinoma.
Zeng XC; Liu FQ; Yan R; Yi HM; Zhang T; Wang GY; Li Y; Jiang N
Mol Cancer; 2014 Dec; 13():261. PubMed ID: 25491321
[TBL] [Abstract][Full Text] [Related]
19. Silencing of lemur tyrosine kinase 2 restricts the proliferation and invasion of hepatocellular carcinoma through modulation of GSK-3β/Wnt/β-catenin signaling.
Zhao G; Song Y; Dong L; Shi H; Li H; Yang L; Wang J
Biochem Biophys Res Commun; 2019 Oct; 517(4):722-728. PubMed ID: 31395338
[TBL] [Abstract][Full Text] [Related]
20. MEIS2C and MEIS2D promote tumor progression via Wnt/β-catenin and hippo/YAP signaling in hepatocellular carcinoma.
Guan L; Li T; Ai N; Wang W; He B; Bai Y; Yu Z; Li M; Dong S; Zhu Q; Ding XX; Zhang S; Li M; Tang G; Xia X; Zhao J; Lin S; Yao S; Zhang L; Chen G; Liu FE; Li X; Zhang H
J Exp Clin Cancer Res; 2019 Oct; 38(1):417. PubMed ID: 31623651
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
